Index
RUT
Market Cap
3.83B
Enterprise Value
3.61B
Income
-702.23M
Sales
682.20M
Book/sh
2.11
Cash/sh
6.28
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
370
IPO
Oct 16, 2020
P/E
-
Forward P/E
174.50
PEG
-
P/S
5.61
P/B
36.81
P/C
12.37
P/FCF
118.05
EV/EBITDA
-
EV/Sales
5.29
Quick Ratio
1.94
Current Ratio
1.96
Debt/Eq
0.85
LT Debt/Eq
0.85
Option/Short
Yes / Yes
EPS (ttm)
-15.18
EPS next Y
0.45
EPS next Q
-0.28
EPS this Y
-878.20%
EPS next Y
102.86%
EPS next 5Y
-
EPS past 3/5Y
14.26% -3.80%
Sales past 3/5Y
159.54% -
EPS Y/Y TTM
-654.07%
Sales Y/Y TTM
86.34%
EPS Q/Q
-4773.76%
Sales Q/Q
63.92%
Insider Own
5.38%
Insider Trans
-3.72%
Inst Own
101.79%
Inst Trans
9.20%
ROA
-135.04%
ROE
-319.84%
ROIC
-364.42%
Gross Margin
93.21%
Oper. Margin
-9.61%
Profit Margin
-102.93%
SMA20
5.65%
SMA50
4.65%
SMA200
13.86%
Trades
Shs Outstand
49.30M
Shs Float
46.65M
52W High
91.53 -15.14%
52W Low
53.89 44.13%
Volatility
4.93% 5.34%
ATR (14)
3.70
RSI (14)
57.34
Beta
0.33
Rel Volume
0.71
Avg Volume
866.87K
Volume
615,448
Perf Week
1.01%
Perf Month
10.17%
Perf Quarter
6.84%
Perf Half Y
22.35%
Perf YTD
-5.14%
Perf Year
0.73%
Perf 3Y
311.82%
Perf 5Y
209.81%
Perf 10Y
-
Prev Close
75.95
Price
77.67
Change %
2.26%
Analysts 11 incl. previous ratings
Rating Distribution 11 Buy · 0 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Sep 24, 2026 Resumed G Goldman
Buy $116 +49.3% Sep 16, 2026 Resumed B Barclays
Overweight $110 +41.6% Apr 24, 2026 Resumed O Oppenheimer
Outperform $105 → $98 +26.2% Dec 09, 2025 Initiated B Barclays
Overweight $100 +28.7% Nov 20, 2025 Initiated M Mizuho
Outperform $100 +28.7% Jun 02, 2025 Resumed O Oppenheimer
Outperform $75 -3.4% May 27, 2025 Resumed H H.C. Wainwright
Buy $72 -7.3% Nov 20, 2023 Initiated G Goldman
Neutral $19 -75.5% Jul 18, 2023 Initiated W William Blair
Outperform $44 -43.4% May 18, 2023 Initiated G Guggenheim
Buy Aug 01, 2022 Initiated B Barclays
Overweight $40 -48.5% Dec 21, 2021 Initiated H H.C. Wainwright
Buy $40 -48.5% Nov 23, 2021 Initiated O Oppenheimer
Outperform $55 -29.2% Nov 10, 2020 Initiated R Raymond James
Strong Buy $39 -49.8% Nov 10, 2020 Initiated L Ladenburg Thalmann
Buy $42 -45.9% Nov 10, 2020 Initiated J Jefferies
Buy $35 -54.9% Nov 10, 2020 Initiated B BofA Securities
Buy $33 -57.5%
Show Previous Ratings
Nov-05-26 04:30PM
Nov-03-26 08:23PM
(Earnings Whispers)
-4.91%
04:05PM
Oct-30-26 09:30AM
Oct-29-26 04:30PM
08:30AM
Loading…
Oct-28-26 08:30AM
Oct-15-26 08:41AM
Sep-29-26 08:30AM
Sep-04-26 08:38AM
Sep-01-26 04:30PM
Aug-07-26 08:13AM
(Pharmaceutical Technology)
Aug-06-26 03:02PM
10:07AM
07:03AM
07:02AM
07:01AM
Loading…
07:01AM
Aug-05-26 08:02PM
Jul-13-26 04:05PM
Jul-10-26 04:04AM
Jul-08-26 04:05PM
(GlobeNewswire)
-4.00%
-5.30%
Jul-01-26 03:28PM
May-28-26 04:30PM
May-14-26 08:30AM
May-07-26 05:00PM
Apr-29-26 04:30PM
Mar-31-26 08:30AM
Mar-26-26 01:08PM
(Investor's Business Daily)
Mar-23-26 08:30AM
Mar-06-26 10:22AM
Mar-02-26 01:13PM
(Investor's Business Daily)
12:58PM
Loading…
Feb-27-26 12:58PM
(Investor's Business Daily)
Feb-26-26 04:30PM
Feb-24-26 12:01AM
Feb-23-26 08:17PM
07:25PM
04:05PM
Feb-20-26 07:17AM
Feb-18-26 10:00AM
08:30AM
Feb-17-26 04:30PM
10:00AM
Feb-02-26 12:27PM
Jan-26-26 09:35AM
Jan-13-26 11:40AM
Nov-24-25 04:30PM
(GlobeNewswire)
+3.08%
-3.93%
Nov-05-25 05:05PM
12:04AM
Nov-04-25 05:55PM
04:05PM
Nov-03-25 07:31AM
Oct-28-25 05:00PM
Oct-09-25 09:27AM
Oct-06-25 06:41AM
Aug-27-25 05:00PM
Aug-25-25 06:33PM
Aug-15-25 10:04AM
(Investor's Business Daily)
Aug-14-25 02:48PM
(Investor's Business Daily)
Aug-06-25 06:00PM
04:05PM
Aug-05-25 09:48AM
Jul-30-25 05:00PM
May-29-25 05:00PM
May-14-25 09:45AM
May-08-25 05:00PM
May-05-25 06:04PM
May-02-25 03:17AM
May-01-25 09:37PM
05:35PM
04:05PM
Apr-30-25 10:17AM
09:55AM
Apr-25-25 10:00AM
Apr-24-25 05:00PM
11:00AM
Apr-23-25 01:41PM
Apr-22-25 11:19AM
08:31AM
Apr-21-25 04:05PM
Mar-28-25 03:59PM
Mar-20-25 09:05AM
Mar-12-25 09:49PM
04:12PM
Mar-06-25 05:00PM
Feb-26-25 02:13AM
(Thomson Reuters StreetEvents)
+3.08%
02:05AM
Feb-25-25 08:40AM
07:00AM
01:31AM
Feb-20-25 05:00PM
Jan-30-25 05:00PM
Jan-20-25 03:31PM
Jan-14-25 09:35AM
Jan-13-25 08:30AM
Dec-26-24 10:30AM
(Investor's Business Daily)
Dec-04-24 09:55AM
Nov-18-24 09:55AM
Nov-14-24 02:15AM
Nov-13-24 05:30PM
04:05PM
08:30AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Azamian Bobak R. President/CEO and Board Chair Nov 13 '26 Sale 80.31 10,000 803,100 817,991 Nov 17 07:00 PM Bobak Azamian Officer Nov 13 '26 Proposed Sale 80.15 10,000 801,500 Nov 13 05:00 PM LINK WILLIAM J PHD Director Sep 15 '26 Sale 78.38 12,500 979,744 94,487 Sep 17 04:22 PM WILLIAM J LINK DIRECTOR Sep 15 '26 Proposed Sale 78.38 12,500 979,745 Sep 15 04:51 PM Azamian Bobak R. President/CEO and Board Chair Sep 04 '26 Sale 90.56 10,000 905,600 827,991 Sep 09 04:14 PM Lin Elizabeth Yeu Chief Medical Officer Sep 04 '26 Sale 87.50 10,773 942,635 2,547 Sep 09 04:13 PM Lin Elizabeth Yeu Chief Medical Officer Sep 04 '26 Sale 87.50 3,180 278,250 1,590 Sep 09 04:13 PM Neervannan Seshadri Chief Operating Officer Sep 04 '26 Sale 85.00 4,564 387,940 78,532 Sep 09 04:12 PM BOBAK AZAMIAN OFFICER Sep 04 '26 Proposed Sale 90.56 10,000 905,587 Sep 04 05:23 PM Lin Elizabeth Yeu Member of immediate family of Sep 04 '26 Proposed Sale 87.50 3,180 278,250 Sep 04 04:03 PM Lin Elizabeth Yeu Officer Sep 04 '26 Proposed Sale 87.50 10,773 942,635 Sep 04 03:59 PM Neervannan Seshadri Officer Sep 04 '26 Proposed Sale 85.00 4,564 387,940 Sep 04 03:36 PM Lin Elizabeth Yeu Chief Medical Officer Sep 02 '26 Sale 80.00 5,387 430,960 13,320 Sep 03 04:29 PM Lin Elizabeth Yeu Chief Medical Officer Sep 01 '26 Sale 73.86 4,601 339,830 18,707 Sep 03 04:29 PM Lin Elizabeth Yeu Chief Medical Officer Sep 02 '26 Sale 80.00 1,590 127,200 4,770 Sep 03 04:29 PM Lin Elizabeth Yeu Member of immediate family of Sep 02 '26 Proposed Sale 80.00 1,590 127,200 Sep 02 04:31 PM Mottiwala Aziz Former Officer Sep 02 '26 Proposed Sale 81.80 8,000 654,373 Sep 02 03:40 PM Lin Elizabeth Yeu Officer Sep 02 '26 Proposed Sale 80.00 5,387 430,960 Sep 02 03:38 PM BOBAK AZAMIAN OFFICER Sep 02 '26 Proposed Sale 80.06 10,000 800,569 Sep 02 02:39 PM Mottiwala Aziz Former Officer Sep 01 '26 Proposed Sale 73.96 77,698 5,746,846 Sep 01 04:09 PM Lin Elizabeth Yeu Officer Sep 01 '26 Proposed Sale 73.86 4,601 339,830 Sep 01 02:23 PM Mottiwala Aziz Former Officer Aug 25 '26 Proposed Sale 71.85 81,332 5,843,887 Aug 25 04:19 PM Mottiwala Aziz Former Officer Aug 19 '26 Proposed Sale 72.00 53,043 3,819,096 Aug 19 02:27 PM Azamian Bobak R. President/CEO and Board Chair Jun 17 '26 Sale 61.55 10,000 615,488 847,991 Jun 22 04:09 PM Farrow Jeffrey S See Remarks Jun 16 '26 Sale 60.95 14,396 877,436 56,801 Jun 17 04:17 PM Goodrich Katherine Director Jun 15 '26 Sale 62.08 2,954 183,384 2,233 Jun 17 04:17 PM LINK WILLIAM J PHD Director Jun 15 '26 Sale 62.12 12,500 776,495 106,786 Jun 17 04:17 PM BOBAK AZAMIAN OFFICER Jun 17 '26 Proposed Sale 61.55 10,000 615,473 Jun 17 02:05 PM Farrow Jeffrey S Officer Jun 16 '26 Proposed Sale 60.95 14,396 877,459 Jun 16 04:53 PM William J Link Director Jun 15 '26 Proposed Sale 62.12 12,500 776,498 Jun 15 04:58 PM Goodrich Katherine Director Jun 15 '26 Proposed Sale 62.08 2,954 183,384 Jun 15 11:44 AM Neervannan Seshadri Chief Operating Officer Mar 20 '26 Sale 66.75 2,989 199,516 82,791 Mar 24 05:05 PM Neervannan Seshadri Officer Mar 20 '26 Proposed Sale 66.75 2,989 199,516 Mar 20 10:38 AM Whitfield Dianne C. Chief Human Resources Officer Mar 18 '26 Sale 68.71 4,071 279,718 39,202 Mar 19 07:04 PM Whitfield Dianne C. Chief Human Resources Officer Mar 17 '26 Sale 69.42 4,029 279,693 43,273 Mar 19 07:04 PM Whitfield Dianne C. Chief Human Resources Officer Mar 19 '26 Sale 67.00 4,174 279,658 35,028 Mar 19 07:04 PM Wahl Bryan General Counsel Mar 17 '26 Sale 69.42 4,084 283,511 72,315 Mar 19 07:04 PM Wahl Bryan General Counsel Mar 19 '26 Sale 67.00 4,231 283,477 63,959 Mar 19 07:04 PM Wahl Bryan General Counsel Mar 18 '26 Sale 68.71 4,125 283,429 68,190 Mar 19 07:04 PM Neervannan Seshadri Chief Operating Officer Mar 19 '26 Sale 67.00 4,589 307,463 85,780 Mar 19 07:04 PM Neervannan Seshadri Chief Operating Officer Mar 18 '26 Sale 68.71 3,610 248,043 90,369 Mar 19 07:04 PM Neervannan Seshadri Chief Operating Officer Mar 17 '26 Sale 69.42 3,125 216,938 93,979 Mar 19 07:04 PM Mottiwala Aziz Chief Commercial Officer Mar 17 '26 Sale 69.42 4,286 297,534 70,250 Mar 19 07:04 PM Mottiwala Aziz Chief Commercial Officer Mar 18 '26 Sale 68.71 4,330 297,514 65,920 Mar 19 07:04 PM Mottiwala Aziz Chief Commercial Officer Mar 19 '26 Sale 67.00 4,440 297,480 61,480 Mar 19 07:04 PM Lin Elizabeth Yeu Chief Medical Officer Mar 19 '26 Sale 67.00 390 26,130 23,308 Mar 19 07:04 PM Lin Elizabeth Yeu Chief Medical Officer Mar 18 '26 Sale 68.71 379 26,041 23,698 Mar 19 07:04 PM Lin Elizabeth Yeu Chief Medical Officer Mar 17 '26 Sale 69.42 375 26,032 24,077 Mar 19 07:04 PM Farrow Jeffrey S See Remarks Mar 18 '26 Sale 68.71 2,133 146,558 45,502 Mar 19 07:03 PM Farrow Jeffrey S See Remarks Mar 17 '26 Sale 69.42 2,111 146,546 47,635 Mar 19 07:03 PM Farrow Jeffrey S See Remarks Mar 19 '26 Sale 67.00 2,186 146,462 43,316 Mar 19 07:03 PM Azamian Bobak R. President/CEO and Board Chair Mar 18 '26 Sale 68.71 11,667 801,640 45,385 Mar 19 07:03 PM Azamian Bobak R. President/CEO and Board Chair Mar 19 '26 Sale 67.00 11,964 801,588 33,421 Mar 19 07:03 PM Azamian Bobak R. President/CEO and Board Chair Mar 17 '26 Sale 69.42 10,972 761,676 57,052 Mar 19 07:03 PM Farrow Jeffrey S Officer Mar 19 '26 Proposed Sale 67.00 2,186 146,459 Mar 19 04:43 PM Mottiwala Aziz Officer Mar 19 '26 Proposed Sale 67.00 4,440 297,475 Mar 19 04:38 PM Azamian Bobak R. Officer Mar 19 '26 Proposed Sale 67.00 11,964 801,574 Mar 19 04:30 PM Whitfield Dianne C. Officer Mar 19 '26 Proposed Sale 67.00 4,174 279,653 Mar 19 04:24 PM Wahl Bryan Officer Mar 19 '26 Proposed Sale 67.00 4,231 283,472 Mar 19 04:23 PM Neervannan Seshadri Officer Mar 19 '26 Proposed Sale 67.00 4,589 307,457 Mar 19 04:15 PM Lin Elizabeth Yeu Officer Mar 19 '26 Proposed Sale 67.00 390 26,130 Mar 19 04:14 PM Whitfield Dianne C. Officer Mar 18 '26 Proposed Sale 68.71 4,071 279,718 Mar 18 04:33 PM Wahl Bryan Officer Mar 18 '26 Proposed Sale 68.71 4,125 283,428 Mar 18 04:18 PM Azamian Bobak R. Officer Mar 18 '26 Proposed Sale 68.71 11,667 801,637 Mar 18 04:17 PM Neervannan Seshadri Officer Mar 18 '26 Proposed Sale 68.71 3,610 248,042 Mar 18 04:17 PM Farrow Jeffrey S Officer Mar 18 '26 Proposed Sale 68.71 2,133 146,558 Mar 18 04:14 PM Mottiwala Aziz Officer Mar 18 '26 Proposed Sale 68.71 4,330 297,513 Mar 18 04:13 PM Lin Elizabeth Yeu Officer Mar 18 '26 Proposed Sale 68.71 379 26,041 Mar 18 04:11 PM LINK WILLIAM J PHD Director Mar 16 '26 Sale 68.79 12,500 859,819 116,332 Mar 18 04:11 PM Azamian Bobak R. Officer Mar 17 '26 Proposed Sale 69.41 10,972 761,618 Mar 17 04:09 PM Neervannan Seshadri Officer Mar 17 '26 Proposed Sale 69.41 3,125 216,921 Mar 17 04:07 PM Farrow Jeffrey S Officer Mar 17 '26 Proposed Sale 69.41 2,111 146,534 Mar 17 04:03 PM Wahl Bryan Officer Mar 17 '26 Proposed Sale 69.41 4,084 283,490 Mar 17 03:59 PM Whitfield Dianne C. Officer Mar 17 '26 Proposed Sale 69.41 4,029 279,672 Mar 17 03:55 PM Lin Elizabeth Yeu Officer Mar 17 '26 Proposed Sale 69.41 375 26,031 Mar 17 03:47 PM Mottiwala Aziz Officer Mar 17 '26 Proposed Sale 69.41 4,286 297,511 Mar 17 03:42 PM WILLIAM J LINK DIRECTOR Mar 16 '26 Proposed Sale 68.78 12,500 859,787 Mar 16 05:39 PM Neervannan Seshadri Chief Operating Officer Mar 04 '26 Sale 76.67 8,366 641,421 70,817 Mar 05 04:03 PM Neervannan Seshadri Officer Mar 04 '26 Proposed Sale 76.67 8,366 641,421 Mar 04 10:56 AM Whitfield Dianne C. Chief Human Resources Officer Jan 02 '26 Sale 80.67 15,565 1,255,684 23,393 Jan 06 04:05 PM Whitfield Dianne C. Officer Jan 02 '26 Proposed Sale 81.38 15,565 1,266,680 Jan 02 11:22 AM Azamian Bobak R. President/CEO and Board Chair Dec 24 '25 Sale 82.51 6,000 495,089 857,991 Dec 30 04:26 PM BOBAK AZAMIAN OFFICER Dec 24 '25 Proposed Sale 82.51 6,000 495,089 Dec 29 12:22 PM Whitfield Dianne C. Chief Human Resources Officer Dec 16 '25 Sale 80.10 7,397 592,500 38,958 Dec 18 04:09 PM LINK WILLIAM J PHD Director Dec 15 '25 Sale 81.43 12,500 1,017,816 128,832 Dec 17 04:07 PM LINK WILLIAM J PHD Director Dec 15 '25 Sale 81.07 10,446 846,862 0 Dec 17 04:07 PM Lin Elizabeth Yeu Chief Medical Officer Dec 16 '25 Sale 79.50 2,078 165,201 21,941 Dec 17 04:07 PM Lin Elizabeth Yeu Officer Dec 16 '25 Proposed Sale 79.50 2,078 165,202 Dec 16 03:12 PM Whitfield Dianne C. Officer Dec 16 '25 Proposed Sale 80.10 7,397 592,500 Dec 16 10:11 AM William Link Director Dec 15 '25 Proposed Sale 81.02 10,446 846,340 Dec 15 04:38 PM WILLIAM J LINK DIRECTOR Dec 15 '25 Proposed Sale 81.42 12,500 1,017,800 Dec 15 04:08 PM
Tarsus Pharmaceuticals, Inc. is a commercial stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis. It is also developing TP-04 for the potential treatment of Ocular Rosacea and TP-05 as an oral tablet for the potential prevention of Lyme disease. The company was founded by Bobak Azamian and D. Michael Ackermann in 2017 and is headquartered in Irvine, CA.
Co-Founder Dr. Bobak R. Azamian M.D.
Chief Operating Officer Dr. Seshadri Neervannan Ph.D.
M.D. Dr. Bryan Wahl J.D.
Head of Investor Relations Mr. David Nakasone
Vice President of Corporate Communications Ms. Adrienne Kemp